pI: 10.123 |
Length (AA): 416 |
MW (Da): 47091 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 6
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
10 | 44 | 4yay (A) | 24 | 58 | 20.00 | 0.35 | 0.03 | -0.0751654 | 3.21 |
240 | 354 | 5u09 (A) | 1172 | 412 | 29.00 | 0.53 | 0.03 | 0.157942 | 1.97 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_138685)
Species | Accession | Gene Product |
---|---|---|
Caenorhabditis elegans | CELE_B0334.6 | Protein B0334.6 |
Drosophila melanogaster | Dmel_CG6986 | Proctolin receptor |
Echinococcus granulosus | EgrG_000356400 | g protein coupled receptor |
Echinococcus granulosus | EgrG_000836800 | 7tm_1 domain containing protein |
Echinococcus multilocularis | EmuJ_000356400 | g protein coupled receptor |
Homo sapiens | 124274 | G protein-coupled receptor 139 |
Loa Loa (eye worm) | LOAG_02548 | hypothetical protein |
Mus musculus | ENSMUSG00000066197 | G protein-coupled receptor 139 |
Onchocerca volvulus | OVOC10230 |
|
Schmidtea mediterranea | mk4.030476.00 | |
Schmidtea mediterranea | mk4.022218.00 | |
Schmidtea mediterranea | mk4.001381.00 | |
Schmidtea mediterranea | mk4.000928.03 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | G protein-coupled receptor 139 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Oryctolagus cuniculus | Growth hormone secretagogue receptor type 1 | 366 aa | 24.0% | 338 aa | Compounds | References |
Sus scrofa | Ghrelin receptor | 366 aa | 23.8% | 340 aa | Compounds | References |
Rattus norvegicus | Ghrelin receptor | 364 aa | 23.7% | 337 aa | Compounds | References |
Rattus norvegicus | Thyrotropin-releasing hormone receptor | 412 aa | 25.1% | 335 aa | Compounds | References |
Rattus norvegicus | Thyrotropin-releasing hormone receptor 2 | 352 aa | 24.5% | 347 aa | Compounds | References |
Macaca mulatta | Mu-type opioid receptor | 400 aa | 22.0% | 359 aa | Compounds | References |
Canis lupus familiaris | Beta-3 adrenergic receptor | 405 aa | 19.3% | 336 aa | Compounds | References |
Ovis aries | Ghrelin receptor | 366 aa | 24.3% | 337 aa | Compounds | References |